K. Dascomb

发表

Extracorporeal Membrane Oxygenation Support in Management of Severe Respiratory Failure Secondary to 2009 Influenza A(H1N1) Virus

Russell R. Miller, Samuel M. Brown, N. Dean, 2010 .

INFLUENZA A(H1N1) INFECTION

Russell R. Miller, Samuel M. Brown, N. Dean, 2010 .

The clinical profile of end-stage AIDS.

P. Kissinger, K. Welch, A. Morse, 1998, AIDS patient care and STDs.

Stewardship in Community Hospitals – Optimizing Outcomes and Resources (SCORE): A Cluster-Randomized Controlled Trial Investigating the Impact of Antibiotic Stewardship in 15 Small, Community Hospitals

R. Srivastava, J. Lloyd, J. Burke, 2016 .

Effectiveness of a Third Dose of mRNA Vaccines Against COVID-19–Associated Emergency Department and Urgent Care Encounters and Hospitalizations Among Adults During Periods of Delta and Omicron Variant Predominance — VISION Network, 10 States, August 2021–January 2022

William F. Fadel, S. E. Reese, C. Mcevoy, 2022, MMWR. Morbidity and mortality weekly report.

Changes in the accuracy of administrative data for the detection of surgical site infections

M. Samore, B. Bucher, K. Dascomb, 2020, Infection Control & Hospital Epidemiology.

Laboratory-Confirmed COVID-19 Among Adults Hospitalized with COVID-19-Like Illness with Infection-Induced or mRNA Vaccine-Induced SARS-CoV-2 Immunity - Nine States, January-September 2021.

William F. Fadel, S. E. Reese, C. Mcevoy, 2021, MMWR. Morbidity and mortality weekly report.

Waning 2-Dose and 3-Dose Effectiveness of mRNA Vaccines Against COVID-19–Associated Emergency Department and Urgent Care Encounters and Hospitalizations Among Adults During Periods of Delta and Omicron Variant Predominance — VISION Network, 10 States, August 2021–January 2022

William F. Fadel, S. E. Reese, C. Mcevoy, 2022, MMWR. Morbidity and mortality weekly report.

Association between COVID-19 mRNA vaccination and COVID-19 illness and severity during Omicron BA.4 and BA.5 sublineage periods

William F. Fadel, S. E. Reese, C. Mcevoy, 2022, medRxiv.

Streptococcus pneumoniae serotypes in Utah adults at the end of the PCV7 era.

C. Byington, E. Mason, A. Pavia, 2011, Vaccine.

Early Streptococcus pneumoniae serotype changes in Utah adults after the introduction of PCV13 in children.

C. Byington, E. Mason, C. Stockmann, 2016, Vaccine.

Trends in Multidrug-Resistant Bacteria and Clostridium difficile in an Integrated Healthcare Network, 2008–2015

J. Burke, E. Stenehjem, R. Mehta, 2016 .

Effectiveness of COVID-19 Vaccines at Preventing Emergency Department or Urgent Care Encounters and Hospitalizations Among Immunocompromised Adults: An Observational Study of Real-World Data Across 10 US States from August-December 2021

S. E. Reese, C. Mcevoy, P. Embí, 2022, medRxiv.

Effectiveness of 2, 3, and 4 COVID-19 mRNA Vaccine Doses Among Immunocompetent Adults During Periods when SARS-CoV-2 Omicron BA.1 and BA.2/BA.2.12.1 Sublineages Predominated — VISION Network, 10 States, December 2021–June 2022

William F. Fadel, S. E. Reese, C. Mcevoy, 2022, MMWR. Morbidity and mortality weekly report.

Effectiveness of COVID-19 mRNA Vaccines Against COVID-19–Associated Hospitalizations Among Immunocompromised Adults During SARS-CoV-2 Omicron Predominance — VISION Network, 10 States, December 2021—August 2022

William F. Fadel, S. E. Reese, C. Mcevoy, 2022, MMWR. Morbidity and mortality weekly report.

Microsporidiosis and HIV.

P. Kissinger, E. Didier, R. Clark, 2000, Journal of acquired immune deficiency syndromes.

Natural History of Intestinal Microsporidiosis among Patients Infected with Human Immunodeficiency Virus

P. Kissinger, J. Aberg, E. Didier, 1999, Journal of Clinical Microbiology.

Influence of seasonal variation with enteric microsporidiosis among HIV-infected individuals.

P. Kissinger, E. Didier, J. Kopicko, 1999, Journal of acquired immune deficiency syndromes.

Risk Factors for Community-Acquired Extended-Spectrum Beta-Lactamase–Producing Enterobacteriaceae Infections—A Retrospective Study of Symptomatic Urinary Tract Infections

N. Dean, K. Dascomb, S. Neill, 2019, Open forum infectious diseases.

Effectiveness of COVID-19 Pfizer-BioNTech BNT162b2 mRNA Vaccination in Preventing COVID-19–Associated Emergency Department and Urgent Care Encounters and Hospitalizations Among Nonimmunocompromised Children and Adolescents Aged 5–17 Years — VISION Network, 10 States, April 2021–January 2022

William F. Fadel, S. E. Reese, M. Stockwell, 2022, MMWR. Morbidity and mortality weekly report.

Effectiveness of Homologous and Heterologous COVID-19 Booster Doses Following 1 Ad.26.COV2.S (Janssen [Johnson & Johnson]) Vaccine Dose Against COVID-19–Associated Emergency Department and Urgent Care Encounters and Hospitalizations Among Adults — VISION Network, 10 States, December 2021–March 2022

William F. Fadel, C. Mcevoy, M. Stockwell, 2022, MMWR. Morbidity and mortality weekly report.

Evaluation of Online Risk Assessment To Identify Rabies Exposures Among Health Care Workers — Utah, 2019

Dallin Peterson, R. Wallace, Jesse Bonwitt, 2020, MMWR. Morbidity and mortality weekly report.

Human Immunodeficiency Virus Infection in Elderly Patients

P. Kissinger, L. Bazzano, K. Desalvo, 2001, Southern medical journal.

Effectiveness of Covid-19 Vaccines in Ambulatory and Inpatient Care Settings

William F. Fadel, S. Schrag, K. Natarajan, 2021, The New England journal of medicine.

Early Estimates of Bivalent mRNA Vaccine Effectiveness in Preventing COVID-19–Associated Emergency Department or Urgent Care Encounters and Hospitalizations Among Immunocompetent Adults — VISION Network, Nine States, September–November 2022

S. E. Reese, C. Mcevoy, R. Link-Gelles, 2022, MMWR. Morbidity and mortality weekly report.

Effectiveness of 2-Dose Vaccination with mRNA COVID-19 Vaccines Against COVID-19–Associated Hospitalizations Among Immunocompromised Adults — Nine States, January–September 2021

William F. Fadel, Sarah E. Reese, C. Mcevoy, 2021, MMWR. Morbidity and mortality weekly report.

Predicting risk of drug-resistant organisms in pneumonia: moving beyond the HCAP model.

N. Dean, E. Stenehjem, K. Dascomb, 2015, Respiratory medicine.

Waning of vaccine effectiveness against moderate and severe covid-19 among adults in the US from the VISION network: test negative, case-control study

William F. Fadel, S. E. Reese, C. Mcevoy, 2022, BMJ.

Effectiveness of two-dose vaccination with mRNA COVID-19 vaccines against COVID-19–associated hospitalizations among immunocompromised adults—Nine States, January–September 2021

S. E. Reese, C. Mcevoy, S. Schrag, 2021, American Journal of Transplantation.

Protection of 2 and 3 mRNA Vaccine Doses Against Severe Outcomes Among Adults Hospitalized with COVID-19 - VISION Network, August 2021 - March 2022.

S. E. Reese, C. Mcevoy, P. Embí, 2022, The Journal of infectious diseases.

Clinical findings and demographic factors associated with ICU admission in Utah due to novel 2009 influenza A(H1N1) infection.

Russell R. Miller, Samuel M. Brown, N. Dean, 2010, Chest.

Estimation of COVID-19 mRNA Vaccine Effectiveness and COVID-19 Illness and Severity by Vaccination Status During Omicron BA.4 and BA.5 Sublineage Periods

William F. Fadel, S. E. Reese, C. Mcevoy, 2023, JAMA network open.

Frequency, Risk Factors, and Outcomes of Vancomycin-Resistant Enterococcus Colonization and Infection in Patients with Newly Diagnosed Acute Leukemia: Different Patterns in Patients with Acute Myelogenous and Acute Lymphoblastic Leukemia

J. Burke, J. Asch, K. Dascomb, 2015, Infection Control & Hospital Epidemiology.

S. E. Reese, C. Mcevoy, R. Link-Gelles, 2023, MMWR. Morbidity and mortality weekly report.

Derivation and Multicenter Validation of the Drug Resistance in Pneumonia Clinical Prediction Score

N. Dean, M. Metersky, H. Vikram, 2016, Antimicrobial Agents and Chemotherapy.

Effectiveness of BNT162b2 COVID-19 Vaccination in Children and Adolescents.

S. E. Reese, M. Stockwell, R. Link-Gelles, 2023, Pediatrics.

Clinical Findings and Demographic Factors Associated With ICU Admission in Utah Due to Novel 2009 Infl uenza A ( H 1 N 1 ) Infection

Russell R. Miller, Samuel M. Brown, N. Dean, 2010 .

Number needed to vaccinate with a COVID-19 booster to prevent a COVID-19-associated hospitalization during SARS-CoV-2 Omicron BA.1 variant predominance, December 2021–February 2022, VISION Network: a retrospective cohort study

R. Link-Gelles, P. Embí, K. Natarajan, 2023, Lancet regional health. Americas.

Vaccine effectiveness against influenza-associated urgent care, emergency department, and hospital encounters during the 2021-2022 season, VISION Network.

C. Mcevoy, P. Embí, B. Flannery, 2023, Journal of Infectious Diseases.

S. E. Reese, C. Mcevoy, R. Link-Gelles, 2023, MMWR. Morbidity and mortality weekly report.

Estimates of Bivalent mRNA Vaccine Durability in Preventing COVID-19-Associated Hospitalization and Critical Illness Among Adults with and Without Immunocompromising Conditions - VISION Network, September 2022-April 2023.

S. E. Reese, C. Mcevoy, R. Link-Gelles, 2023, American Journal of Transplantation.

Estimates of Bivalent mRNA Vaccine Durability in Preventing COVID-19–Associated Hospitalization and Critical Illness Among Adults with and Without Immunocompromising Conditions — VISION Network, September 2022–April 2023

William F. Fadel, S. E. Reese, C. Mcevoy, 2023, MMWR. Morbidity and mortality weekly report.

Effectiveness of Monovalent and Bivalent mRNA Vaccines in Preventing COVID-19–Associated Emergency Department and Urgent Care Encounters Among Children Aged 6 Months–5 Years — VISION Network, United States, July 2022–June 2023

S. E. Reese, M. Stockwell, R. Link-Gelles, 2023, MMWR. Morbidity and mortality weekly report.

Estimating the Incidence of Influenza at the State Level — Utah, 2016–17 and 2017–18 Influenza Seasons

M. Biggerstaff, C. Reed, P. Gesteland, 2019, MMWR. Morbidity and mortality weekly report.